clinical trial · NCT06462118
A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects
Genentech, Inc.·phase1·completed·n = 78
Healthy VolunteersAstegolimab
brief summary
The main objective is to study how astegolimab may behave in the body when injected subcutaneously into the abdomen, thigh, or upper arm in healthy participants.
started
Jun 17, 2024
primary completion
Oct 22, 2024
completion
Oct 22, 2024
last updated
Jan 30, 2025
official title
A Phase 1, Open-Label, Randomized, Single Dose Study to Evaluate the Effect of Injection Site on the Pharmacokinetics of Astegolimab in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol